Proteins offer an alternative: they recognise metals via programmable binding pockets and can be engineered for affinity, selectivity, and process compatibility

availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial

People start looking into it when joints feel worn, progress stops, or injuries keep returning
We are working with researchers to address this problem but it is still early days yet
I love my skin
Whether your goal is accelerated weight loss, joint and tissue repair, deep sleep, or systemic anti-aging, our medical team will prescribe the exact molecular sequence your body needs